{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:59:54Z","timestamp":1773770394274,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00415-018-9151-x","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T10:57:52Z","timestamp":1544180272000},"page":"440-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Guillain\u2013Barr\u00e9 syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-0204","authenticated-orcid":false,"given":"Helle","family":"Al-Hakem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren H.","family":"Sindrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Dornonville","family":"de la Cour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth L.","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Harbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"9151_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Berg van den","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J et al (2014) Guillain\u2013Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10:469\u2013482. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"9151_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1212\/01.WNL.0000149521.65474.83","volume":"64","author":"C DornonvilleCour de la","year":"2005","unstructured":"Dornonville de la Cour C, Jakobsen J (2005) Residual neuropathy in long-term population-based follow-up of Guillain\u2013Barr\u00e9 syndrome. Neurology 64:246\u2013253. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000149521.65474.83","journal-title":"Neurology"},{"key":"9151_CR3","volume-title":"Cochrane database of systematic reviews","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA (2014) Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome. In: Hughes RA (ed) Cochrane database of systematic reviews. Wiley, Chichester"},{"key":"9151_CR4","volume-title":"Cochrane database of systematic reviews","author":"JC Rapha\u00ebl","year":"2002","unstructured":"Rapha\u00ebl JC, Chevret S, Hughes RA, Annane D (2002) Plasma exchange for Guillain\u2013Barr\u00e9 syndrome. In: Annane D (ed) Cochrane database of systematic reviews. Wiley, Chichester"},{"key":"9151_CR5","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome. Ann Neurol 27:S21\u2013S24. \n                    https:\/\/doi.org\/10.1002\/ana.410270707","journal-title":"Ann Neurol"},{"key":"9151_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J et al (2014) Diagnosis of Guillain\u2013Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137:33\u201343. \n                    https:\/\/doi.org\/10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"9151_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J et al (2011) Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29:599\u2013612. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.003","journal-title":"Vaccine"},{"key":"9151_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jns.12189","volume":"21","author":"MB Islam","year":"2016","unstructured":"Islam MB, Islam Z, Farzana KS et al (2016) Guillain\u2013Barr\u00e9 syndrome in Bangladesh: validation of Brighton criteria. J Peripher Nerv Syst 21:345\u2013351. \n                    https:\/\/doi.org\/10.1111\/jns.12189","journal-title":"J Peripher Nerv Syst"},{"key":"9151_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123\u2013133. \n                    https:\/\/doi.org\/10.1159\/000324710","journal-title":"Neuroepidemiology"},{"key":"9151_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12209","author":"BC Jacobs","year":"2017","unstructured":"Jacobs BC, van den Berg B, Verboon C et al (2017) International Guillain\u2013Barre Syndrome Outcome Study (IGOS): protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain\u2013Barre syndrome. J Peripher Nerv Syst. \n                    https:\/\/doi.org\/10.1111\/jns.12209","journal-title":"J Peripher Nerv Syst"},{"key":"9151_CR11","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","volume":"141","author":"AY Doets","year":"2018","unstructured":"Doets AY, Verboon C, van den Berg B et al (2018) Regional variation of Guillain\u2013Barr\u00e9 syndrome. Brain 141:2866\u20132877. \n                    https:\/\/doi.org\/10.1093\/brain\/awy232","journal-title":"Brain"},{"key":"9151_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Uncini A, Yuki N (2014) Guillain\u2013Barre and Miller Fisher syndromes\u2013new diagnostic classification. Nat Rev Neurol 10:537\u2013544. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2014.138","journal-title":"Nat Rev Neurol"},{"key":"9151_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jnnp-2013-305397","volume":"85","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Yuki N (2014) Pharyngeal-cervical-brachial variant of Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry 85:339\u2013344. \n                    https:\/\/doi.org\/10.1136\/jnnp-2013-305397","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9151_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750\u2013753. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(78)92644-2","journal-title":"Lancet"},{"key":"9151_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RDM Hadden","year":"1998","unstructured":"Hadden RDM, Cornblath DR, Hughes RAC et al (1998) Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome. Ann Neurol 44:780\u2013788. \n                    https:\/\/doi.org\/10.1002\/ana.410440512","journal-title":"Ann Neurol"},{"key":"9151_CR16","unstructured":"Statistics Denmark (2017) Statbank Denmark. \n                    http:\/\/www.statistikbanken.dk\/statbank5a\/default.asp?w=1280\n                    \n                  . Accessed 16 April 2017"},{"key":"9151_CR17","first-page":"3093","volume":"172","author":"CA Leo","year":"2010","unstructured":"Leo CA, Sindrup SH, Gaist D (2010) Unchanged incidence of Guillain\u2013Barre syndrome in the Funen county during a decade. Ugeskr Laeger 172:3093\u20133097","journal-title":"Ugeskr Laeger"},{"key":"9151_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain\u2013Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123\u2013133. \n                    https:\/\/doi.org\/10.1159\/000324710","journal-title":"Neuroepidemiology"},{"key":"9151_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain\u2013Barr\u00e9 syndrome worldwide. A systematic literature review. Neuroepidemiology 32:150\u2013163. \n                    https:\/\/doi.org\/10.1159\/000184748","journal-title":"Neuroepidemiology"},{"key":"9151_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000369344","volume":"43","author":"S Hense","year":"2014","unstructured":"Hense S, Schink T, Kreisel SH et al (2014) Estimation of background incidence rates of Guillain-Barr\u00e9 syndrome in Germany\u2014a retrospective cohort study with electronic healthcare data. Neuroepidemiology 43:244\u2013252. \n                    https:\/\/doi.org\/10.1159\/000369344","journal-title":"Neuroepidemiology"},{"key":"9151_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00019052-200110000-00009","volume":"14","author":"V Govoni","year":"2001","unstructured":"Govoni V, Granieri E (2001) Epidemiology of the Guillain\u2013Barr\u00e9 syndrome. Curr Opin Neurol 14:605\u2013613","journal-title":"Curr Opin Neurol"},{"key":"9151_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000438752","volume":"45","author":"MD Benedetti","year":"2015","unstructured":"Benedetti MD, Pugliatti M, D\u2019Alessandro R et al (2015) A multicentric prospective incidence study of Guillain\u2013Barr\u00e9 syndrome in Italy. The ITANG Study. Neuroepidemiology 45:90\u201399. \n                    https:\/\/doi.org\/10.1159\/000438752","journal-title":"Neuroepidemiology"},{"key":"9151_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/jns.12202","volume":"22","author":"A Delannoy","year":"2017","unstructured":"Delannoy A, Rudant J, Chaignot C et al (2017) Guillain\u2013Barr\u00e9 syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008\u20132013). J Peripher Nerv Syst 22:51\u201358. \n                    https:\/\/doi.org\/10.1111\/jns.12202","journal-title":"J Peripher Nerv Syst"},{"key":"9151_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jns.12239","volume":"22","author":"JOT Sipil\u00e4","year":"2017","unstructured":"Sipil\u00e4 JOT, Soilu-H\u00e4nninen M, Ruuskanen JO et al (2017) Epidemiology of Guillain\u2013Barr\u00e9 syndrome in Finland 2004\u20132014. J Peripher Nerv Syst 22:440\u2013445. \n                    https:\/\/doi.org\/10.1111\/jns.12239","journal-title":"J Peripher Nerv Syst"},{"key":"9151_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jns.12096","volume":"19","author":"S Peric","year":"2014","unstructured":"Peric S, Milosevic V, Berisavac I et al (2014) Clinical and epidemiological features of Guillain\u2013Barre syndrome in the Western Balkans. J Peripher Nerv Syst 19:317\u2013321. \n                    https:\/\/doi.org\/10.1111\/jns.12096","journal-title":"J Peripher Nerv Syst"},{"key":"9151_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.33.5.633","volume":"33","author":"JE Kaplan","year":"1983","unstructured":"Kaplan JE, Schonberger LB, Hurwitz ES, Katona P (1983) Guillain\u2013Barre syndrome in the United States, 1978\u20131981: additional observations from the national surveillance system. Neurology 33:633\u2013637","journal-title":"Neurology"},{"key":"9151_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejpn.2008.04.009","volume":"13","author":"M Rabie","year":"2009","unstructured":"Rabie M, Nevo Y (2009) Childhood acute and chronic immune-mediated polyradiculoneuropathies. Eur J Paediatr Neurol 13:209\u2013218. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2008.04.009","journal-title":"Eur J Paediatr Neurol"},{"key":"9151_CR28","unstructured":"Asbury AK, Asbury A, Carrell-Krusen Symposium invited lecture new concepts of Guillain\u2013Barr\u00e9 syndrome"},{"key":"9151_CR29","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00415-012-6806-x","volume":"260","author":"J Witsch","year":"2013","unstructured":"Witsch J, Galldiks N, Bender A et al (2013) Long-term outcome in patients with Guillain\u2013Barr\u00e9 syndrome requiring mechanical ventilation. J Neurol 260:1367\u20131374. \n                    https:\/\/doi.org\/10.1007\/s00415-012-6806-x","journal-title":"J Neurol"},{"key":"9151_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry 83:711\u2013718. \n                    https:\/\/doi.org\/10.1136\/jnnp-2011-301882","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9151_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R Koningsveld van","year":"2007","unstructured":"van Koningsveld R, Steyerberg EW, Hughes RAC et al (2007) A clinical prognostic scoring system for Guillain\u2013Barr\u00e9 syndrome. Lancet Neurol 6:589\u2013594. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(07)70130-8","journal-title":"Lancet Neurol"},{"key":"9151_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain\u2013Barre syndrome. Neurology 76:968\u2013975. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182104407","journal-title":"Neurology"},{"key":"9151_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/jns.12163","volume":"21","author":"S Peric","year":"2016","unstructured":"Peric S, Berisavac I, Stojiljkovic Tamas O et al (2016) Guillain\u2013Barr\u00e9 syndrome in the elderly. J Peripher Nerv Syst 21:105\u2013110. \n                    https:\/\/doi.org\/10.1111\/jns.12163","journal-title":"J Peripher Nerv Syst"},{"key":"9151_CR34","doi-asserted-by":"publisher","first-page":"II96","DOI":"10.1007\/s00415-007-2024-3","volume":"254","author":"P Flachenecker","year":"2007","unstructured":"Flachenecker P (2007) Autonomic dysfunction in Guillain\u2013Barr\u00e9 syndrome and multiple sclerosis. J Neurol 254:II96\u2013II101. \n                    https:\/\/doi.org\/10.1007\/s00415-007-2024-3","journal-title":"J Neurol"},{"key":"9151_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/mus.25551","volume":"56","author":"C Anandan","year":"2017","unstructured":"Anandan C, Khuder SA, Koffman BM (2017) Prevalence of autonomic dysfunction in hospitalized patients with Guillain\u2013Barr\u00e9 syndrome. Muscle Nerve 56:331\u2013333. \n                    https:\/\/doi.org\/10.1002\/mus.25551","journal-title":"Muscle Nerve"},{"key":"9151_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.56.6.758","volume":"56","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP et al (2001) Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome. Neurology 56:758\u2013765. \n                    https:\/\/doi.org\/10.1212\/WNL.56.6.758","journal-title":"Neurology"},{"key":"9151_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-018-0542-y","author":"Z Zaeem","year":"2018","unstructured":"Zaeem Z, Siddiqi ZA, Zochodne DW (2018) Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update. Clin Auton Res. \n                    https:\/\/doi.org\/10.1007\/s10286-018-0542-y","journal-title":"Clin Auton Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9151-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:10:58Z","timestamp":1575659458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9151-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9151"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9151-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"14 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors received no specific funding for this work. Thomas Harbo has received speakers\u2019 honoraria from CSL Behring. Bart Jacobs reports grants from Baxalta, grants from Grifols, grants from CSL-Behring, grants from Annexon, grants from Prinses-Beatrix Spierfonds, grants from GBS-CIDP Foundation International, outside the submitted work. The remaining authors report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The manuscript does not contain patient data. Permission to obtain and process data was granted by the Danish Data Protection Agency [reference number 1-16-02-3-16] and the Danish Patient Safety Authority [reference number 3-3013-1449\/1\/].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}